Nanomedicine's promising therapy: Magnetic drug targeting

Expert Review of Medical Devices

Volumn 8, Issue 3, 2011, Pages 291-294

  Kempe, Henrik ^a   Kates, Steven A ^b   Kempe, Maria ^a  

^a LUND UNIVERSITY   (Sweden)

^b Ischemix   (United States)

Author keywords

drug delivery; magnetic drug targeting; nanomedicine; nanoparticles; stents

Indexed keywords

FERRIC OXIDE; MAGNETIC NANOPARTICLE; MAGNETITE; PACLITAXEL; TISSUE PLASMINOGEN ACTIVATOR;

DRUG DELIVERY SYSTEM; DRUG TARGETING; HUMAN; IN-STENT RESTENOSIS; MEDICAL TECHNOLOGY; NANODEVICE; NANOMEDICINE; REVIEW;

ANIMALS; DRUG DELIVERY SYSTEMS; HUMANS; MAGNETICS; NANOMEDICINE; NANOPARTICLES; PROSTHESES AND IMPLANTS;

EID: 79955773305     PISSN: 17434440     EISSN: 17452422     Source Type: Journal    
DOI: 10.1586/erd.10.94     Document Type: Review

References (26)

1. Wang M, Thanou M. Targeting nanoparticles to cancer. Pharmacol. Res. 62(2), 90-99 (2010).
2. Tillander H. Magnetic guidance of a catheter with articulated steel tip. Acta Radiol. 35(1), 62-64 (1951).
3. Meyers PH, Cronic F, Nice CM. Experimental approach in the use and magnetic control of metallic iron particles in the lymphatic and vascular system of dogs as a contrast and isotopic agent. Am. J. Roentgenol. Radium Ther. Nucl. Med. 90, 1068-1077 (1963).
4. Widder KJ, Senyei AE, Scarpelli DG. Magnetic microspheres: a model system for site specific drug delivery in vivo. Proc. Soc. Exp. Biol. Med. 158(2), 141-146 (1978). (Pubitemid 8386575)
5. Mosbach K, Schroder U. Preparation and application of magnetic polymers for targeting of drugs. FEBS Lett. 102(1), 112-116 (1979). (Pubitemid 9193095)
6. Tartaj P, Morales MP, Veintemillas-Verdaguer S, Gonzalez-Carreno T, Serna CJ. Synthesis, properties and biomedical applications of magnetic nanoparticles. In:Handbook of Magnetic Materials. Buschow KHJ (Ed.), Elsevier, Amsterdam, The Netherlands, 403-482 (2006).
7. Vereda F, de Vicente J, del Puerto Morales M, Rull F, Hidalgo-Ivarez R. Synthesis and characterization of single-domain monocrystalline magnetite particles by oxidative aging of Fe(OH)2. J. Phys. Chem. C 112(15), 5843-5849 (2008).
8. Puzyn T, Leszczynska D, Leszczynski J. Toward the development of 'nano-QSARs': advances and challenges. Small 5(22), 2494-2509 (2009).
9. Gupta AK, Gupta M. Synthesis and surface engineering of iron oxide nanoparticles for biomedical applications. Biomaterials 26(18), 3995-4021 (2005). (Pubitemid 40044762)
10. Li M, Al-Jamal KT, Kostarelos K, Reineke J. Physiologically based pharmacokinetic modeling of nanoparticles. ACS Nano. 4(11), 6303-6317 (2010).
11. Alexiou C, Diehl D, Henninger P et al. A high field gradient magnet for magnetic drug targeting. IEEE Trans. Appl. Supercond. 16(2), 1527-1530 (2006). (Pubitemid 44150135)
12. Nishijima S, Mishima F, Tabata Y et al. Research and development of magnetic drug delivery system using bulk high temperature superconducting magnet. IEEE Trans. Appl. Supercond. 19(3), 2257-2260 (2009).
13. Huang Z, Pei N, Wang Y et al. Deep magnetic capture of magnetically loaded cells for spatially targeted therapeutics. Biomaterials 31(8), 2130-2140 (2010).
14. Ritter JA, Ebner AD, Daniel KD, Stewart KL. Application of high gradient magnetic separation principles to magnetic drug targeting. J. Magn. Magn. Mater. 280(2-3), 184-201 (2004).
15. Chen H, Ebner AD, Rosengart AJ, Kaminski MD, Ritter JA. Analysis of magnetic drug carrier particle capture by a magnetizable intravascular stent: 1. Parametric study with single wire correlation. J. Magn. Magn. Mater. 284, 181-194 (2004).
16. Chen H, Ebner AD, Kaminski MD, Rosengart AJ, Ritter JA. Analysis of magnetic drug carrier particle capture by a magnetizable intravascular stent-2: parametric study with multi-wire two-dimensional model. J. Magn. Magn. Mater. 293(1), 616-632 (2005). (Pubitemid 40608988)
17. Avilés MO, Chen H, Ebner AD, Rosengart AJ, Kaminski MD, Ritter JA. In vitro study of ferromagnetic stents for implant assisted-magnetic drug targeting. J. Magn. Magn. Mater. 311(1), 306-311 (2007). (Pubitemid 46400979)
18. Avilés MO, Ebner AD, Ritter JA. Implant assisted-magnetic drug targeting: comparison of in vitro experiments with theory. J. Magn. Magn. Mater. 320(21), 2704-2713 (2008).
19. Cregg PJ, Murphy K, Mardinoglu A. Calculation of nanoparticle capture efficiency in magnetic drug targeting. J. Magn. Magn. Mater. 320(23), 3272-3275 (2008).
20. Cregg PJ, Murphy K, Mardinoglu A. Inclusion of magnetic dipole-dipole and hydrodynamic interactions in implant-assisted magnetic drug targeting. J. Magn. Magn. Mater. 321(23), 3893-3898 (2009).
21. Watson JHP. Status of superconducting magnetic separation in the minerals industry. Miner. Eng. 7(5-6), 737-746 (1994).
22. Polyak B, Fishbein I, Chorny M et al. High field gradient targeting of magnetic nanoparticle-loaded endothelial cells to the surfaces of steel stents. Proc. Natl Acad. Sci. USA 105(2), 698-703 (2008). (Pubitemid 351171771)
23. Chorny M, Fishbein I, Yellen BB et al. Targeting stents with local delivery of paclitaxel-loaded magnetic nanoparticles using uniform fields. Proc. Natl Acad. Sci. USA 107(18), 8346-8351 (2010).
24. Kempe M, Kempe, H, Snowball I et al. The use of magnetite nanoparticles for implant-assisted magnetic drug targeting in thrombolytic therapy. Biomaterials 31(36), 9499-9510 (2010).
25. Garg S, Serruys PW. Coronary stents. Looking forward. J. Am. Cardiol. 56(10), S43-S78 (2010).
26. Burgess P, Barton Hutt P, Farokhzad OC, Langer R, Minick S, Zale S. On firm ground: IP protection of therapeutic nanoparticles. Nat. Biotechnol. 28(12), 1267-1270 (2010).